{"id":"W4282941936","doi":"10.1158/1538-7445.am2022-1794","title":"Abstract 1794: The combination of Talazoparib with anti-her2 drugs shows efficacy in drug resistant Her2+ and low Her2 PDX models","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"","keywords":"Pertuzumab; Trastuzumab; Medicine; Breast cancer; PARP inhibitor; Cancer research; Cancer; Combination therapy; SKBR3; Internal medicine; Oncology; Poly ADP ribose polymerase; Biology; Polymerase; DNA","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002041403,0.0004235873,0.0004225923,0.0002874846,0.0001960673,0.0004289244,0.0004364623,0.0003906026,0.003116356],"category_scores_gemma":[0.00009512402,0.0001334564,0.0003219245,0.0002454319,0.0002300582,0.0002496256,0.0001463323,0.001296484,0.0005665975],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004917755,"about_ca_system_score_gemma":0.0003480711,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00151061,"about_ca_topic_score_gemma":0.001840712,"domain_scores_codex":[0.9998424,0.00002127577,0.00001507883,0.00002657025,0.00004810159,0.0000463767],"domain_scores_gemma":[0.9998977,0.00001437996,0.00002302747,0.00001010185,0.00000958401,0.00004521102],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002891056,0.001657202,0.0006900163,0.0001202646,0.00004691023,0.0001268312,0.00003408625,0.000701707,0.9853802,0.0002608786,0.002017595,0.006073301],"study_design_scores_gemma":[0.0006704463,0.01065622,0.00588459,0.00001054953,0.00006659744,0.0004680987,0.00005587673,0.002400496,0.9738787,0.00006809318,0.00582832,0.00001199309],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928543,0.0008001508,0.0008167131,0.00027948,0.0000916471,0.0001133515,0.002205939,0.0001381867,0.002700312],"genre_scores_gemma":[0.9871593,0.0009116786,0.001747706,0.000154855,0.00002986341,0.000179889,0.003437153,0.00003695374,0.006342545],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003116356,"threshold_uncertainty_score":0.01042527,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06037064049450164,"score_gpt":0.3836592425164361,"score_spread":0.3232886020219345,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}